Article information
Special issue
This article is part of special issue:
Vol. 64. Issue S3
Supplement “Pulmonary Interstitial Pathology”
More infoAbstract
Systemic autoimmune diseases comprise a complex, heterogeneous group of entities. Noteworthy among the pulmonary complications of these entities is interstitial involvement, which manifests with the same radiopathologic patterns as in idiopathic interstitial pneumonia. High-resolution computed tomography is the gold-standard imaging technique; it enables us to identify and classify the disease and to determine its extent, providing useful information about the prognosis. In this group of processes, the most common pattern of presentation is nonspecific interstitial pneumonia. It is essential for radiologists to work together in collaboration with other specialists to reach the correct diagnosis and enable appropriate, integrated treatment.
Keywords:
Interstitial lung disease
Computed tomography
High-resolution computed tomography
Connective tissue disease
Systemic autoimmune disease
Resumen
Las enfermedades autoinmunes sistémicas son un grupo heterogéneo y complejo de entidades. Entre sus complicaciones pulmonares destaca la afectación intersticial, que se manifiesta con los mismos patrones radiopatológicos descritos en las neumonías intersticiales idiopáticas. La tomografía computarizada de alta resolución es la técnica de imagen de referencia, que permite identificar, clasificar y determinar la extensión de la enfermedad pulmonar, aportando datos pronósticos. En este grupo de procesos el patrón de afectación más común es el de neumonía intersticial no específica. La colaboración del radiólogo con otros especialistas resulta esencial tanto para alcanzar el diagnóstico correcto como para un manejo adecuado e integral del paciente.
Palabras clave:
Enfermedades pulmonares intersticiales
Tomografía computarizada
Tomografía computarizada de alta resolución
Enfermedades del tejido conectivo
Enfermedades autoinmunes sistémicas
Article
These are the options to access the full texts of the publication Radiología (English Edition)
Subscriber
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
A. Fischer, J.S. Lee, V. Cottin.
Interstitial lung disease evaluation: detecting connective tissue disease.
Respiration, 90 (2015), pp. 177-184
[2]
M. Sebastiani, C. Vacchi, G. Cassone, A. Manfredi.
Diagnosis, clinical features and management of interstitial lung diseases in rheumatic disorders: still a long journey.
J Clin Med, 11 (2022), pp. 410
[3]
KG Kallianos, BM Elicker, TS Henry.
Approach to the patient with connective tissue disease and diffuse lung disease.
Semin Roentgenol, 54 (2019), pp. 21-29
[4]
A. Fischer, K.M. Antoniou, K.K. Brown, J. Cadranel, T.J. Corte, R.M. du Bois, et al.
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Eur Respir J, 46 (2015), pp. 976-987
[5]
A.S. Jee, R. Sheehy, P. Hopkins, T.J. Corte, C. Grainge, L.K. Troy, et al.
Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand.
Respirology, 26 (2021), pp. 23-51
[6]
T. Méndez-Rayo, L. Ochoa-Zárate, I. Posso-Osorio, E. Ortiz, J. Naranjo-Escobar, G.J. Tobón.
Interpretación de los autoanticuerpos en enfermedades reumatológicas.
Rev Colomb Reumatol, 25 (2019), pp. 112-125
[7]
E.F. Vicente-Rabaneda, D.A. Bong, S. Castañeda, I. Möller.
Use of ultrasound to diagnose and monitor interstitial lung disease in rheumatic diseases.
Clin Rheumatol, 40 (2021), pp. 3547-3564
[8]
W.D. Travis, U. Costabel, D.M. Hansell, TE King Jr, DA Lynch, AG Nicholson, et al.
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
Am J Respir Crit Care Med, 188 (2013), pp. 733-748
[9]
JE Kusmirek, JP Kanne.
Thoracic manifestations of connective tissue diseases.
Semin Ultrasound CT MRI, 40 (2018), pp. 239-254
[10]
J. Capobianco, A. Grimberg, B.M. Thompson, V.B. Antunes, D. Jasinowodolinski, G.S. Meirelles.
Thoracic manifestations of collagen vascular diseases.
Radiographics, 32 (2012), pp. 33-50
[11]
J. Ahuja, D. Arora, J. Kanne, S.H. Travis, J.D. Dodwin.
Imaging of pulmonary manifestations of connective tissue diseases.
Radiol Clin N Am, 54 (2016), pp. 1015-1031
[12]
C.I.S. Silva, N.L. Müller, D.A. Lynch, D. Curran-Everett, K.K. Brown, K.S. Lee, et al.
Chronic hypersensitivity pneumonitis: Differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT.
Radiology, 246 (2008), pp. 288-297
[13]
J.H. Chung, C.W. Cox, S.M. Montner, A. Adegunosoye, J.M. Oldham, A.N. Husain.
CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis.
AJR Am J Roentgenol, 210 (2018), pp. 307-313
[14]
I. Mira-Avendano, A. Abril, C.D. Burger, P.F. Dellaripa, A. Fischer, M.B. Gotway, et al.
Interstitial lung disease and other pulmonary manifestations in connective tissue diseases.
Mayo Clin Proc, 94 (2019), pp. 309-325
[15]
GUIPCAR 17. Guía de práctica clínica para el manejo de pacientes con artritis reumatoide. Sociedad Española de Reumatología. Año 2019.
[16]
L.K. Groner, D.B. Green, S.V. Weisman, A.C. Legasto, D. Toy, J.E. Gruden, et al.
Thoracic manifestations of rheumatoid arthritis.
RadioGraphics, 41 (2021), pp. 32-55
[17]
A.J. Esposito, S.G. Chu, R. Madan, T.J. Doyle, P.F. Dellaripa.
Thoracic manifestations of rheumatoid arthritis.
Clin Chest Med, 40 (2019), pp. 545-560
[18]
S.R. Desai, D.A. Lynch, B.M. Elicker, A. Devaraj, N. Sverzellati.
Connective tissue diseases.
Webb, Müller and Naidich’s high-resolution CT of the lung, 6.ª ed., pp. 259-279
[19]
G. Raghu, M. Remy-Jardin, J.L. Myers, L. Richeldi, C.J. Ryerson, D.J. Lederer, et al.
Diagnosis of idiopathic pulmonary fibrosis: an official ATS/ERS/JRS/ALAT clinical practice guideline.
Am J Respir Crit Care Med, 198 (2018), pp. 44-68
[20]
D.A. Lynch, N. Sverzellati, W.D. Travis, K.K. Brown, T.V. Coby, J.R. Galvin, et al.
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society white paper.
Lancet Respir Med, 6 (2018), pp. 138-153
[21]
J Jacob, N Hirani, CHM van Moorsel, S Rajagopalan, JT Murchison, ESHW van, et al.
Predicting outcomes in rheumatoid arthritis related interstitial lung disease.
Eur Respir J, 53 (2019),
[22]
J. Jacob, J.W. Song, H.Y. Yoon, G. Cross, J. Barnett, W.L. Woo, et al.
Prevalence and effects of emphysema in never smokers with rheumatoid arthritis interstitial lung disease.
E Bio Medicine, 28 (2018), pp. 303-310
[23]
D. Strollo, J. Goldin.
Imaging lung disease in systemic sclerosis.
Curr Rheumatol Rep, 12 (2010), pp. 156-161
[24]
D. Khanna, O. Distler, V. Cottin, K.K. Brown, L. Chung, J. Goldin, et al.
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.
J Sclerodema Relat Disord, (2022),
[25]
L. Gargani, C. Bruni, C. Romei, P. Frumento, A Moreo, G Agoston, et al.
Prognostic value of lung ultrasound B-lines in systemic sclerosis.
Chest, 158 (2020), pp. 1515-1525
[26]
A.M. Ferrazza, A. Gigante, M.L. Gasperini, R.M. Ammendola, G. Paone, I. Carbone, et al.
Assessment of interstitial lung disease in systemic sclerosis using the quantitative algorithm CALIPER.
Clin Rheumatol, 39 (2020), pp. 1537-1542
[27]
C. Kloth, A.C. Blum, W.M. Thaiss, H. Preibsch, H. Ditt, R. Grimmer, et al.
Differences in texture analysis parameters between active alveolitis and lung fibrosis in chest CT of patients with systemic sclerosis: a feasibility study.
Acad Radiol, 24 (2017), pp. 1596-1603
[28]
J. Barnett, A. Devaraj.
Computed tomographic imaging in connective tissue diseases.
Semin Respir Crit Care Med, 40 (2019), pp. 159-172
[29]
D. Launay, M. Remy-Jardin, U. Michon-Pasturel, I. Mastora, E. Hachulla, M. Lambert, et al.
High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.
J Rheumatol, 33 (2006), pp. 1789-1801
[30]
N.S.L. Goh, S.R. Desai, S. Veeraraghavan, D.M. Hansell, S.J. Copley, T.M. Maher, et al.
Interstitial lung disease in systemic sclerosis. A simple staging system.
Am J Respir Crit Care Med, 177 (2008), pp. 1248-1254
[31]
T. Flament, A. Bigot, B. Chaigne, H. Henique, E. Diot, S. Marchand-Adam.
Pulmonary manifestations of Sjögren’s syndrome.
Eur Respir Rev, 25 (2016), pp. 110-123
[32]
R. Egashira, T. Kondo, T. Hirai, N. Kamochi, M. Yakushiji, F. Yamasaki, et al.
CT findings of thoracic manifestations of primary Sjögren syndrome: radiologic-pathologic correlation.
Radiographics, 33 (2013), pp. 1933-1949
[33]
A.S. Lee, R.H. Scofield, K.M. Hammitt, N. Gupta, D.E. Thomas, T. Moua, et al.
Consensus guidelines for evaluation and management of pulmonary disease in Sjögren’s syndrome.
Chest, 159 (2021), pp. 683-698
[34]
S. Gupta, M.A. Ferrada, S.A. Hasni.
Pulmonary manifestations of primary Sjögren’s syndrome: underlying immunological mechanisms, clinical presentation, and management.
Front Immunol, 10 (2019), pp. 1327
[35]
M. Uffman, H.P. Kiener, A.A. Bankier, M.M. Baldt, T. Zontsich, C.J. Herold.
Lung manifestation in asymptomatic patients with primary Sjogren syndrome: Assessment with high resolution CT and pulmonary function tests.
J Thorac Imaging, 16 (2001), pp. 282-289
[36]
F. Luppi, M. Sebastiani, M. Silva, N. Sverzellati, A. Cavazza, C. Salvarani, et al.
Interstitial lung disease in Sjögren’s syndrome: a clinical review.
Clin Exp Rheumatol, 38 (2020), pp. 291-300
[37]
M. Ramos-Casals, P. Brito-Zerón, R. Seror, H. Bootsma, S.J. Bowman, T. Dörner, et al.
Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.
Rheumatology (Oxford), 54 (2015), pp. 2230-2238
[38]
L.A. Saketkoo, D.P. Ascherman, V. Cottin, L. Christopher-Stine, S.K. Danoff, C.V. Oddis.
Interstitial lung disease in idiopathic inflammatory myopathy.
Curr Rheumatol Rev, 6 (2010), pp. 108-119
[39]
N. Sawal, S. Mukhopadhyay, S. Rayancha, A. Moore, P. Garcha, A. Kumar, et al.
A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach.
J Thorac Dis, 13 (2021), pp. 5556-5571
[40]
J.C. Lega, Q. Reynaud, A. Belot, N. Fabien, I. Durieu, V. Cottin.
Idiopathic inflammatory myopathies and the lung.
Eur Respir Rev, 24 (2015), pp. 216-238
[41]
V. Cottin, F. Thivolet-Béjui, M. Reynaud-Gaubert, J. Cadranel, P. Delaval, P.J. Ternamian, et al.
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis.
Eur Respir J, 22 (2003), pp. 245-250
[42]
E. Bodolay, Z. Szekanecz, K. Dévényi, L. Galuska, I. Csípo, J. Vègh, et al.
Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).
Rheumatology (Oxford), 44 (2005), pp. 656-661
[43]
B. Crestani.
The respiratory system in connective tissue disorders.
Allergy, 60 (2005), pp. 715-734
[44]
M.A. Burdt, R.W. Hoffman, S.L. Deutscher, Gs Wang, J.C. Johnson, G.C. Sharp, et al.
Longterm outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.
Arthritis Rheum, 42 (1999), pp. 899-909
[45]
S. Di Bartolomeo, A. Alunno, F. Carubbi.
Respiratory manifestations in systemic lupus erythematosus.
Pharmaceuticals, 14 (2021), pp. 276
[46]
J. Narváez, H. Borrell, F. Sánchez-Alonso, I. Rúa-Figueroa, F.J. López-Longo, M. Galindo-Izquierdo, et al.
Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort.
Arthritis Res Ther, 20 (2018), pp. 280
[47]
G. Aguilera-Pickens, C. Abud-Mendoza.
Manifestaciones pulmonares en el lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa.
Reumatol Clin, 14 (2018), pp. 294-300
[48]
D. Brady, E.A. Berkowitz, A. Sharma, J.B. Ackman, A. Bernheim, M. Chung, et al.
CT Morphologic characteristics and variant patterns of interstitial pulmonary fibrosis in systemic lupus erythematosus.
Radiol Cardiothorac Imaging, 3 (2021),
[49]
S. Kadura, G. Raghu.
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review.
Eur Respir Rev, 30 (2021), pp. 210-223
[50]
M.A. Alba, L.F. Flores-Suárez, A.G. Henderson, H. Xiao, P. Hu, P.H. Nachman, et al.
Interstitial lung disease in ANCA vasculitis.
Autoimmun Rev, 16 (2017), pp. 722-729
[51]
Y. Katsumata, Y. Kawaguchi, H. Yamanaka.
Interstitial lung disease with ANCA-associated vasculitis.
Clin Med Insights Circ Respir Pulm Med, 9 (2015), pp. 51-56
[52]
L. Fernandes, M. Nasser, K. Ahmad, V. Cottin.
Interstitial pneumonia with autoimmune features.
Front Med, 6 (2019), pp. 209
[53]
V. Cottin, N.A. Hirani, D.L. Hotchkin, A.M. Nambiar, T. Ogura, M. Otaola, et al.
Presentation, diagnosis and clinical course of the spectrum of progressive fibrosing interstitial lung diseases.
Eur Respir Rev, 27 (2018),
